- Finland
- /
- Paper and Forestry Products
- /
- HLSE:UPM
A Look At The Intrinsic Value Of UPM-Kymmene Oyj (HEL:UPM)
Key Insights
- The projected fair value for UPM-Kymmene Oyj is €39.24 based on 2 Stage Free Cash Flow to Equity
- With €31.64 share price, UPM-Kymmene Oyj appears to be trading close to its estimated fair value
- Analyst price target for UPM is €36.42 which is 7.2% below our fair value estimate
Today we will run through one way of estimating the intrinsic value of UPM-Kymmene Oyj (HEL:UPM) by projecting its future cash flows and then discounting them to today's value. This will be done using the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.
Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.
Check out our latest analysis for UPM-Kymmene Oyj
The Model
We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today's dollars:
10-year free cash flow (FCF) forecast
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (€, Millions) | €1.15b | €1.39b | €1.53b | €1.61b | €1.67b | €1.71b | €1.75b | €1.78b | €1.81b | €1.83b |
Growth Rate Estimate Source | Analyst x7 | Analyst x5 | Analyst x2 | Analyst x1 | Est @ 3.61% | Est @ 2.77% | Est @ 2.18% | Est @ 1.76% | Est @ 1.47% | Est @ 1.27% |
Present Value (€, Millions) Discounted @ 8.5% | €1.1k | €1.2k | €1.2k | €1.2k | €1.1k | €1.0k | €989 | €927 | €867 | €809 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = €10b
The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.8%. We discount the terminal cash flows to today's value at a cost of equity of 8.5%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = €1.8b× (1 + 0.8%) ÷ (8.5%– 0.8%) = €24b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= €24b÷ ( 1 + 8.5%)10= €11b
The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is €21b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of €31.6, the company appears about fair value at a 19% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.
The Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at UPM-Kymmene Oyj as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.5%, which is based on a levered beta of 1.373. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for UPM-Kymmene Oyj
- Debt is not viewed as a risk.
- Earnings declined over the past year.
- Dividend is low compared to the top 25% of dividend payers in the Forestry market.
- Annual earnings are forecast to grow faster than the Finnish market.
- Current share price is below our estimate of fair value.
- Dividends are not covered by earnings.
- Annual revenue is forecast to grow slower than the Finnish market.
Next Steps:
Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. It's not possible to obtain a foolproof valuation with a DCF model. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For UPM-Kymmene Oyj, there are three important aspects you should assess:
- Risks: For instance, we've identified 2 warning signs for UPM-Kymmene Oyj that you should be aware of.
- Future Earnings: How does UPM's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the HLSE every day. If you want to find the calculation for other stocks just search here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About HLSE:UPM
UPM-Kymmene Oyj
Engages in the forest-based bioindustry in Europe, North America, Asia, and internationally.
Undervalued with excellent balance sheet.